1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
  5. > MediPoint: Nuclear Imaging - Current and Future Players

MediPoint: Nuclear Imaging - Current and Future Players

  • December 2014
  • -
  • Global Data
  • -
  • 133 pages

MediPoint: Nuclear Imaging - Current and Future Players

Summary

This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets. PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report PET imaging uses Positron Emitting radioactive tracers with a short half life, to image metabolically active organs PET combined with CT allows precise anatomical imaging of the body, identifying diseased areas depending upon the tracer used PET/CT is most often used for cancer diagnosis PET/MRI is a new technique that was introduced to reduce patient exposure to radiation PET only systems are now generally considered obsolete, due to the superior imaging quality of PET/CT

The nuclear imaging market is a mature yet dynamic market with several players competing for market share. The competitive landscape consists of large, mid-size, and small companies that are involved in the manufacture and distribution of nuclear imaging systems. Three companies - GE Healthcare, Philips Healthcare, and Siemens Healthcare - dominate the market in all geographies. The remaining smaller companies are either regional companies that are struggling to compete with the multinational companies by offering general imaging equipment, or small companies producing specialist nuclear imaging systems aimed at diagnosing diseases in specific parts of the body. The major players are profiled in the upcoming section, which underlines their current product offerings and strategic initiatives.

Scope

- Investigation of current and future market competition for Nuclear Imaging.
- Competitor assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Nuclear Imaging in clinical practice.

Reasons to buy

- Gain a high level view of the trends shaping and driving the Nuclear Imaging market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market

Table Of Contents

MediPoint: Nuclear Imaging - Current and Future Players
1 Table of Contents
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 8
3 Competitive Assessment 9
3.1 Overview 9
3.2 Dedicated PET Systems 9
3.2.1 Overview 9
3.2.2 Product Profile 10
3.2.3 SWOT Analysis 11
3.3 PET/CT Systems 11
3.3.1 Overview 11
3.3.2 Product Profiles 12
3.3.3 SWOT Analysis 14
3.4 PET/MRI Systems 14
3.4.1 Overview 14
3.4.2 Product Profile 16
3.4.3 SWOT Analysis 17
3.5 Dedicated SPECT Systems 17
3.5.1 Overview 17
3.5.2 Product Profile 19
3.5.3 SWOT Analysis 20
3.6 SPECT/CT Systems 21
3.6.1 Overview 21
3.6.2 Product Profile 23
3.6.3 SWOT Analysis 24
3.7 PET/Ultrasound and SPECT/Ultrasound Systems 25
3.7.1 Overview 25
3.7.2 Product Profile 25
3.7.3 SWOT Analysis 26
4 Pipeline Assessment 27
4.1 Overview 27
4.2 Pipeline by Phases in Development 28
4.3 Product Profiles 28
4.3.1 Brain Biosciences CerePET 28
4.3.2 ECORAD Dual Modality Imager 30
4.3.3 FMI Technologies ScintiStar PET/CT 31
4.3.4 IntraMedical Imaging Marginator Beta Camera 33
4.3.5 INSERT SPECT/MRI 34
4.3.6 Nucare/Zecotek Photonics New Generation PET Scanning Device 37
4.3.7 Philips Healthcare PET Alpha Ring Detector 38
4.3.8 Photo Diagnostic Systems NeuroPET/CT 39
4.3.9 SynchroPET Breast PET/MRI 40
4.3.10 SynchroPET Wrist Scanner 41
4.3.11 SurgicEye SPECT Hybrid 42
5 Clinical Trials to Watch 44
5.1 Overview 44
5.2 Clinical Trial Profiles 44
6 Current and Future Players 47
6.1 Overview 47
6.2 Trends in Corporate Strategy 47
6.3 Company Profiles 48
6.3.1 DDD-Diagnostic 48
6.3.2 Digirad 50
6.3.3 GE Healthcare 54
6.3.4 GVI Medical Devices 59
6.3.5 Mediso Medical Imaging Systems 62
6.3.6 NeuroLogica 64
6.3.7 Neusoft Medical Systems 66
6.3.8 NuCare Medical Systems 69
6.3.9 Oncovision 71
6.3.10 Philips Healthcare 73
6.3.11 Shimadzu 80
6.3.12 Siemens Healthcare 85
6.3.13 SurgicEye 90
6.3.14 Toshiba Medical 93
6.3.15 Other Companies 98
7 Appendix 101
7.1 Abbreviations 101
7.2 Bibliography 105
7.3 Methodology 122
7.3.1 Overview 122
7.3.2 Coverage 122
7.3.3 Secondary Research 122
7.4 Physicians and Specialists Included in This Study 124
7.5 Primary Research 126
7.5.1 Primary Research - Key Opinion Leader Interviews 126
7.5.2 Expert Panel Validation 126
7.5.3 Stakeholder Survey 127
7.6 Forecasting Methodology 129
7.7 About the Authors 130
7.7.1 Andrew Thompson, PhD, Senior Analyst 130
7.7.2 Priya Radhakrishnan, MBA, Director, Medical Devices 130
7.7.3 Bonnie Bain, PhD, Global Head of Healthcare 131
7.8 About GlobalData 132
7.9 Disclaimer 132

1.1 List of Tables

Table 1: Dedicated PET Scanners 10
Table 2: Dedicated PET SWOT Analysis 11
Table 3: PET/CT Scanners 12
Table 4: PET/CT SWOT Analysis 14
Table 5: PET/MRI Systems 16
Table 6: PET/MRI SWOT Analysis 17
Table 7: Dedicated SPECT Systems 19
Table 8: Dedicated SPECT SWOT Analysis 20
Table 9: SPECT/CT Systems 23
Table 10: SPECT/CT SWOT Analysis 24
Table 11: SPECT-Ultrasound Systems 25
Table 12: SPECT/Ultrasound SWOT Analysis 26
Table 13: Nuclear Imaging Pipeline, 2014 28
Table 14: CerePET SWOT Analysis 30
Table 15: ECORAD Dual Modality Imager SWOT Analysis 31
Table 16: ScintiStar PET/CT SWOT Analysis 33
Table 17: Marginator SWOT Analysis 34
Table 18: INSERT SPECT-MRI SWOT Analysis 37
Table 19: Nucare/Zecotek Photonics New Generation PET Scanning Device SWOT Analysis 38
Table 20: PET Alpha Ring Detector 39
Table 21: NeuroPET/CT Scanner SWOT Analysis 40
Table 22: SynchroPET Breast PET/MRI SWOT Analysis 41
Table 23: SynchroPET Wrist Scanner 42
Table 24: SurgicEye SPECT/Ultrasound device SWOT Analysis 43
Table 25: Key Clinical Trials 45
Table 26: Company Profile - DDD-Diagnostic 48
Table 27: DDD-Diagnostic SWOT Analysis 50
Table 28: Company Profile - Digirad 51
Table 29: Digirad SWOT Analysis 54
Table 30: Company Profile - GE Healthcare 55
Table 31: GE Healthcare Product Portfolio 56
Table 32: GE Healthcare SWOT Analysis 59
Table 33: Company Profile - GVI Medical Devices 60
Table 34: GVI Medical Devices SWOT Analysis 61
Table 35: Company Profile - Mediso Medical Imaging Systems 62
Table 36: Mediso Medical Imaging Systems SWOT Analysis 63
Table 37: Company Profile - Neurologica 64
Table 38: Neurologica SWOT Analysis 66
Table 39: Company Profile - Neusoft Medical Systems 67
Table 40: Neusoft Medical Systems SWOT Analysis 69
Table 41: Company Profile - NuCare Medical Systems 70
Table 42: Nucare Medical Systems SWOT Analysis 71
Table 43: Company Profile - Oncovision 72
Table 44: Oncovision SWOT Analysis 73
Table 45: Company Profile - Philips Healthcare 74
Table 46: Philips Healthcare SWOT Analysis 80
Table 47: Company Profile - Shimadzu 81
Table 48: Shimadzu SWOT Analysis 84
Table 49: Company Profile - Siemens Healthcare 85
Table 50: Siemens Healthcare SWOT Analysis 90
Table 51: Company Profile - SurgicEye 91
Table 52: SurgicEye SWOT Analysis 93
Table 53: Company Profile - Toshiba Medical 94
Table 54: Toshiba Medical SWOT Analysis 97
Table 55: Other Companies in the Nuclear Imaging Market, 2014 98
Table 56: Primary Research Summary 127
Table 57: Primary Research Participants Affiliation 128

1.2 List of Figures

Figure 1: Primary Research Summary 127
Figure 2: Primary Research Participants Affiliation 128

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Computed Tomography (CT) Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

Global Computed Tomography (CT) Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers

  • $ 7400
  • Industry report
  • August 2016
  • by Venture Planning Group

This report provides diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, ...

Computed Tomography (CT) Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers--M&A, Technological Capabilities, Marketing Tactics, Joint Ventures, Strategic Directions

Computed Tomography (CT) Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers--M&A, Technological Capabilities, Marketing Tactics, Joint Ventures, Strategic Directions

  • $ 7400
  • Industry report
  • September 2016
  • by Venture Planning Group

This report provides diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, ...

Small Animal Imaging Market by Modality, Reagent - Global forecast to 2021

Small Animal Imaging Market by Modality, Reagent - Global forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global small animal imaging market is estimated to grow at a high CAGR of 6.2% during 2016-2021; and is projected to be valued at USD 910.4 million by 2021. Market growth in the global small animal ...

Global Imaging Agents Industry

September 2016 $ 4950

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.